Target intelligence / Profile preview

Kinase or Protease

Molecular classification
Enzyme
01

Overview

Kinase or Protease refers to two distinct and expansive superfamilies of enzymes that play fundamental roles in cellular physiology and are major focuses of modern pharmacology. Kinases are enzymes that catalyze the transfer of a phosphate group from ATP to specific substrates, a process known as phosphorylation that acts as a primary switch for signal transduction, cell growth, and metabolism (Manning et al., 2002). Proteases, or peptidases, are enzymes that catalyze the hydrolysis of peptide bonds, facilitating protein degradation, processing of signaling molecules, and blood coagulation (Puente et al., 2003). While both classes are critical therapeutic targets, the term Kinase or Protease is a broad categorical grouping rather than a specific molecular target. Dysregulation of kinases is frequently linked to oncogenesis and inflammatory disorders, whereas protease dysfunction is associated with viral infections, cardiovascular diseases, and neurodegeneration (Rawlings et al., 2018). Consequently, drugs targeting these enzymes, such as small-molecule kinase inhibitors or protease inhibitors, must be highly selective to avoid significant off-target toxicity arising from the high degree of structural conservation within these enzyme families (Roskoski, 2021).

Other names
PhosphotransferasesPeptidasesProteolytic enzymesProtein kinasesProteinases
02

Mechanism of action

Kinase inhibitors typically act via ATP-competitive or allosteric inhibition to block phosphorylation, while protease inhibitors bind to the active site to prevent proteolytic cleavage of substrate proteins.

03

Biological functions

Signal transductionProtein degradationCell cycle regulationApoptosisMetabolismBlood coagulation
04

Disease associations

CancerInflammationViral infectionCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Off-target toxicity due to structural conservationCardiotoxicityMetabolic disturbancesDrug-drug interactions
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Phosphorylated protein levelsProteolytic cleavage fragmentsD-dimerProstate-specific antigen (PSA)

Beyond the preview

Go deeper on Kinase or Protease.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinase or Protease.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call